Bayer Puts Marketing Muscle Behind Yaz
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is exclusively promoting the oral contraceptive Yaz in the U.S. as it looks to drive uptake over Yasmin.
You may also be interested in...
Onyx Expects Early 2008 Launch For Nexavar In Liver Cancer
Firm expects more off-label use of Nexavar in liver cancer in second half of 2007.
Onyx Expects Early 2008 Launch For Nexavar In Liver Cancer
Firm expects more off-label use of Nexavar in liver cancer in second half of 2007.
Nektar/Bayer Agree To Develop Inhaled Amikacin For Hospital-Acquired Pneumonia
Product combining Nektar’s deep-lung delivery technology and amikacin formulation could reach market in 2010-2011 timeframe, Nektar COO tells “The Pink Sheet” DAILY.